10 - "natural experiment"
11 - social distancing
12 - case numbers
15 - infections
16 - equilibrium setpoint
17 - mathematical model
18 - lockdown efficacies
19 - vaccination coverage
20 - estimates
21 - observed phenomena
22 - longitudinal analysis
23 - SARS-CoV-2
24 - lockdown and vaccine efficacy
25 - Keywords
26 - COVID-19
27 - epidemiology
28 - infection dynamics
38 - viral expansion
39 - national vaccination
41 - regions within nations
42 - longitudinal modeling
43 - SIR model
44 - mathematical epidemiology
45 - virus, its host
46 - s-curve trajectory
47 - COVID-19 dynamics
48 - complexity
49 non-trivial equilibrium setpoint.
50 A key criterion of epidemic expansion
51 basic reproductive number (Ro)
52 active infectious individual
53 SIR or similar models
54 Ro≥1
55 Ro<1
99 - data shape
100 - Inclusion criteria
101 - 10-fold mean difference between PCR tests and positive confirmed cases
102 - high GDP (PPP) per capita
103 - approximately one log decrease in infections from peak to minimum rates during lockdowns
104 - 45 units qualifying
105 - 24 European nations, Australia and New Zealand, the UK and the four nations constituting the UK, 10 USA states, and four Asian nations
106 - Lockdown interventions, mobility and vaccination coverage
107 - Dates for national policy lockdown initiation and termination
108 - COVID-19 stringency index
109 - Mobility
110 - 4 doses of vaccine
120 - βVS
121 - δI
122 - pI
123 - cV
128 - η(t)
129 - 1/δ
130 - p/c
135 - Ro=βσp/(δc)
136 - r2+(δ+c)r+δc(1−Ro)
137 - r=δ(Ro−1)
148 - β'=βp/c
155 - r='S1−, where S1 is the level of available susceptibles at t1
156 - r can be obtained directly from the observed slope on the semi-log graph
157 - its doubling-time is t2=ln(2)/r
159 - Initially, infections rise exponentially
160 - During stringent lockdown and effective cessation of viral transmission, between t0 and t1
161 - infection decays exponentially with a half-life of t½=ln(2)/r0
162 - where r0 is derived from the slope of the ln-transformed infection data
174 - Ro=1+r(r++c)/c
175 - Ro=1+r/
180 - n
182 - Oi and Pi are the observed and expected values, for n datapoints
184 - ( ) t    0  , otherwise  for each intervention wave
185 - the proportion of the population needed to be vaccinated in order to block community spread, known as "herd immunity" threshold is [47,48]:
188 - H=1−1
Figure 2. COVID-19 case levels for 10 nations with no or ineffective lockdowns
Table 1. COVID-19 kinetic characteristics in countries with no effective lockdowns
growth steady state State weeks logI ± SD rate t2 Argentina 0.2 2.8 25 2.2 ± 0.3
Brazil 0.6 1.1 13 2.4 ± 0.2
Chile 0.4 1.6 13 2.4 ± 0.3
Colombia 0.3 2.4 21 2.4 ± 0.3
Costa Rica 0.5 1.3 26 2.4 ± 0.5
Ecuador 1.3 0.5 19 1.9 ± 0.1
El Salvador 0.4 1.7 17 1.8 ± 0.3
India 1.1 0.6 20 3.9 ± 0.5
Iran 0.2 4.1 45 2.3 ± 0.4
Figure 4. COVID-19 positive confirmed cases ten US states conforming to inclusion criteria from February 2020 to September 2021.
Australia and New Zealand: February 2020 to September 2021
Israel: 1.5 weeks, 1.3, 0.3, 2.2, 33, 37, 0.7, 1.0, 2.6 ± 0.3, 93, 1.8, 0.17, 0.5, 1.3, 0.3, 2.7, 0.3, 2.2, 44, 29, 2.4 ± 0.3
Luxembourg: 1.9, 0.15, 0.6, 1.2, 0.4, 1.7, 0.4, 1.9, 47, 30, 2.5 ± 0.1
New Zealand: 1.7, 0.33, 0.6, 1.1, 1.5, 0.5, 0.2, 3.1, 40, 2.0 ± 0.3
Norway: 1.5, 0.19, 0.4, 1.8, 0.4, 1.8, 0.2, 3.3, 33, 22, 1.3 ± 0.2
Slovenia: 1.4, 0.19, 0.7, 0
281 - decay and rebound slopes among countries of similar magnitude
282 - infection waves within countries
285 - initial exponential growth phase
286 - basic reproductive number (Ro)
288 - recovery/removal rate constant
290 -  (0.4-0.5)
291 - r (0.2-0.3)
293 - Herd immunity and inhibition of infection by vaccination
305 - COVID-19 cases
307 - prior to vaccination deployment
313 - initial exponential phase of the pandemic
316 - physical contact
317 - infection rates by 10-fold
319 - interventions to block COVID-19
321 - statistically significant parameters
None
2.3 - England and Wales
2.0 - England and Wales
2.1 - England and Wales
49 - EarlyCOVID-19 studies
50 - EarlyCOVID-19 studies
51 - Historical influenza pandemics
52 - Seasonal influenza outbreaks
53 - Some studies
45 - Israel
1.03 - Israel
30 - Herd immunity threshold
1.2 - Post-lockdown rebounds doubling times
0.3 - Post-lockdown rebounds doubling times
4.4 - First five infection waves
10.6 - First five infection waves
450 Estimating the generation interval and inferring the latent period of COVID-19 from the contact tracing data. 
451 Epidemics. 2021;36: 100482.
452 doi:10.1016/j.epidem.2021.100482
453 Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data.
454 J Clin Med. 2020;9: 538.
455 doi:10.3390/jcm9020538
456 The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application.
457 Ann Intern Med. 2020;172: 577–582.
458 doi:10.7326/M20-0504
459 World Dev Indic Database. 2021;International Comparison Program.
478 SIAM J Appl Math. 2003;63: 1313–1327.
480 Masters Thesis, Bar Ilan University. 2000.
481 Nat Rev Immunol. 2002;2: 28–36.
482 doi:10.1038/nri700
483 J
Israel 60 0.59    Reproduction number
Italy 99 0.51    Reproduction number
Netherlands 50 0.6    Reproduction number
Norway 80 0.47    Reproduction number
Slovenia 75 0.35    Reproduction number
Switzerland 50 0.69    Reproduction number
England 66 0.34    Reproduction number
Wales 80 0.34    Reproduction number
Scotland 61 0.31    Reproduction number
N. Ireland 72 0.29    Reproduction number
Malaysia 50 0.6    Reproduction number
Singapore 60 0.4    Reproduction number
Connecticut 75 0.55    Reproduction number
Illinois 83 0.50    Reproduction number
Massachusetts 99 0.49    Reproduction number
N. Hampshire 91 0.51    Reproduction number
New Jersey 44 0.80    Reproduction number
New York 84 0.47    Reproduction number
Pennsylvania 65 0.41    Reproduction number
Rhode Island 98 0.61    Reproduction number
18 0.12    Reproduction number
69 0.51    Reproduction number
62-75 0.46-0.56    Reproduction number
